Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers of diabetic nephropathy: A 2017 update
Nektaria Papadopoulou‐Marketou, Christina Kanaka‐Gantenbein, Nikolaos Marketos, et al.
Critical Reviews in Clinical Laboratory Sciences (2017) Vol. 54, Iss. 5, pp. 326-342
Closed Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Yiwen Li, Yanfei Liu, Shiwei Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 239
Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management
Mahaboob Khan Sulaiman
Diabetology & Metabolic Syndrome (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 182
Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation
Qichao Hu, Yuan Chen, Xinyu Deng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114252-114252
Open Access | Times Cited: 99
Diabetic Nephropathy - a Review of Risk Factors, Progression, Mechanism, and Dietary Management
Natesan Vijayakumar, Sungjin Kim
Biomolecules & Therapeutics (2021) Vol. 29, Iss. 4, pp. 365-372
Open Access | Times Cited: 90
Excessive Activation of Notch Signaling in Macrophages Promote Kidney Inflammation, Fibrosis, and Necroptosis
Tian‐Kui Ma, Xin Li, Yonghong Zhu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 68
Alteration of gut microbial profile in patients with diabetic nephropathy
Xi Du, Jia Liu, Xue Yu, et al.
Endocrine (2021) Vol. 73, Iss. 1, pp. 71-84
Closed Access | Times Cited: 65
Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia
Guido Gembillo, Ylenia Ingrasciotta, Salvatore Crisafulli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4824-4824
Open Access | Times Cited: 60
Outer membrane vesicles derived from gut microbiota mediate tubulointerstitial inflammation: a potential new mechanism for diabetic kidney disease
Pei Pei Chen, Jia Xiu Zhang, Xue Qi Li, et al.
Theranostics (2023) Vol. 13, Iss. 12, pp. 3988-4003
Open Access | Times Cited: 22
<p>Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-κB and TGF-β1/Smad3 Signaling Pathways in Diabetic Nephropathy</p>
Zhichao Zheng, Wei Zhu, Lei Lei, et al.
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 4135-4148
Open Access | Times Cited: 57
Survival and analysis of predictors of mortality in patients undergoing replacement renal therapy: a 20-year cohort
Emily de Souza Ferreira, Tiago Ricardo Moreira, Rodrigo Gomes da Silva, et al.
BMC Nephrology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 54
Mesenchymal stem cells alleviate rat diabetic nephropathy by suppressing CD103+DCs‐mediated CD8+T cell responses
Fuping Zhang, Chengshi Wang, Xin Wen, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 10, pp. 5817-5831
Open Access | Times Cited: 51
Ferulic acid ameliorates renal injury via improving autophagy to inhibit inflammation in diabetic nephropathy mice
Ruyu Ma, Yinghao He, Qing Fang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113424-113424
Open Access | Times Cited: 33
The clinical impact of growth differentiation factor-15 in heart disease: A 2019 update
Maria Arkoumani, Nektaria Papadopoulou‐Marketou, Nicolas C. Nicolaides, et al.
Critical Reviews in Clinical Laboratory Sciences (2019) Vol. 57, Iss. 2, pp. 114-125
Closed Access | Times Cited: 48
Identification of Potential Serum Metabolic Biomarkers of Diabetic Kidney Disease: A Widely Targeted Metabolomics Study
Hang Zhang, Jingjing Zuo, Sisi Dong, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 39
Novel Biomarkers for the diagnosis of diabetic nephropathy.
Marcio Concepción, Juan Carlos Quiroz, Jacsel Suárez, et al.
PubMed (2024) Vol. 15, Iss. 3, pp. 382-391
Closed Access | Times Cited: 5
MicroRNA as novel biomarkers and therapeutic targets in diabetic kidney disease: An update
Qinghua Cao, Xinming Chen, Chunling Huang, et al.
FASEB BioAdvances (2019) Vol. 1, Iss. 6, pp. 375-388
Open Access | Times Cited: 38
Nephroprotective effect of Vanillic acid in STZ-induced diabetic rats
Savita Kumari, Anjoo Kamboj, Manish Wanjari, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 1, pp. 571-582
Open Access | Times Cited: 31
Increased serum asprosin is correlated with diabetic nephropathy
Rui Wang, Peng Lin, Huibo Sun, et al.
Diabetology & Metabolic Syndrome (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Capability of intravoxel incoherent motion and diffusion tensor imaging to detect early kidney injury in type 2 diabetes
Haoran Zhang, Peng Wang, Dafa Shi, et al.
European Radiology (2022) Vol. 32, Iss. 5, pp. 2988-2997
Closed Access | Times Cited: 20
Urinary Extracellular Vesicles in Chronic Kidney Disease: From Bench to Bedside?
Charlotte Delrue, Sander De Bruyne, Reinhart Speeckaert, et al.
Diagnostics (2023) Vol. 13, Iss. 3, pp. 443-443
Open Access | Times Cited: 12
PREVENTING DIABETIC KIDNEY DISEASE: A SYSTEMATIC REVIEW OF CURRENT PHARMACOLOGICAL APPROACHES
B Dharani, STEPHY SEBASTIAN, Shermin Nazrin, et al.
International Journal of Applied Pharmaceutics (2025), pp. 68-81
Open Access
Danggui Buxue Decoction Regulates Autophagy to Improve Renal Fibrosis in diabetes through miR-27a /PI3K/AKT pathway
Nan Wang, Hui Feng, Ziwei Zhang, et al.
Journal of Ethnopharmacology (2025), pp. 119357-119357
Closed Access
Risk factor assessment of prediabetes and diabetes based on epidemic characteristics in new urban areas: a retrospective and a machine learning study
Li Xu, Xiangcheng Sun, Ning Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Targeting inflammation and necroptosis in diabetic kidney disease: A novel approach via PPARα modulation
Yu Wang, Xiaojian Feng, Yue Li, et al.
International Immunopharmacology (2025) Vol. 154, pp. 114562-114562
Closed Access
The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathyviathe miR‐449a/b/Trim11/Mek signaling pathway
Wenyun Chen, Rui Peng, Yan Sun, et al.
The FASEB Journal (2019) Vol. 33, Iss. 10, pp. 11492-11506
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top